4-(Diethylamino)but-2-ynyl Acetate
- CAS No.22396-77-6
- GradeIndustrial / Pharmaceutical
- Availability● In Stock
High-purity liquid intermediate essential for pharmaceutical synthesis. Ideal for producing anticholinergic agents with consistent quality and reliable supply.
Request Bulk PricingProduct Technical Details
Product Overview
4-(Diethylamino)but-2-ynyl Acetate represents a critical building block in the realm of advanced organic synthesis, specifically tailored for the pharmaceutical industry. This sophisticated chemical compound features a unique structural combination of an alkyne group, a tertiary amine, and an ester functionality, making it highly versatile for complex molecular constructions. As a key precursor, it plays an indispensable role in the manufacturing of specific therapeutic agents, particularly within the anticholinergic class. Our commitment to excellence ensures that every batch meets rigorous international standards, providing researchers and production facilities with a reliable foundation for their synthesis pathways.
We understand that consistency in chemical properties is paramount for downstream processing. Therefore, our manufacturing protocols are designed to minimize impurities and maximize yield stability. This product is not merely a commodity but a specialized component that requires precise handling and quality assurance to ensure the efficacy of the final pharmaceutical products. By choosing our supply, partners gain access to a streamlined procurement process backed by decades of industry expertise.
Technical Specifications
To facilitate accurate integration into your production workflows, we provide comprehensive physical and chemical data. Each parameter is verified through advanced analytical methods including gas chromatography and refractive index measurement. The following table outlines the standard specifications for this material:
| Parameter | Specification |
|---|---|
| CAS Number | 22396-77-6 |
| Molecular Formula | C10H17NO2 |
| Molecular Weight | 183.25 g/mol |
| Appearance | Colorless to Pale Yellow Liquid |
| Purity | ≥98.0% |
| Density | 0.961 g/mL at 25 °C |
| Boiling Point | 217-218 °C |
| Refractive Index | 1.456 |
| Flash Point | 218 °F |
Quality Assurance And Storage
Maintaining the integrity of 4-(Diethylamino)but-2-ynyl Acetate during storage and transit is crucial for preserving its chemical stability. Our quality assurance team implements strict controls at every stage of the supply chain. Upon completion of synthesis, the product undergoes multiple quality checks to verify purity levels and physical constants. We provide a Certificate of Analysis (COA) with every shipment, ensuring full transparency and traceability.
For optimal preservation, this chemical should be stored in a cool and dry environment within well-closed containers. It is essential to keep the material away from moisture, strong light, and excessive heat to prevent degradation. Our standard packaging consists of 25kg cardboard drums, which are designed to protect the contents from physical damage and environmental exposure during global shipping. Custom packaging solutions are available upon request to meet specific logistical requirements.
Industrial Applications
This intermediate is primarily utilized in the synthesis of complex pharmaceutical active ingredients. Its specific structural properties make it an ideal candidate for constructing molecules that require precise spatial arrangement and functional group compatibility. Key advantages of sourcing this material from our facility include:
- Consistent high purity levels ensuring reliable reaction outcomes.
- Scalable production capacity to meet both R&D and commercial manufacturing needs.
- Robust supply chain management for timely global delivery.
- Technical support available for synthesis optimization and troubleshooting.
By leveraging our high-quality intermediates, pharmaceutical manufacturers can accelerate their development timelines and reduce the risk of batch failures. We are dedicated to supporting the advancement of medical therapeutics through the supply of superior chemical building blocks.
